{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:49:14Z","timestamp":1788281354264,"version":"build-2803163510"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK122638"],"award-info":[{"award-number":["DK122638"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK126413"],"award-info":[{"award-number":["DK126413"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK108736"],"award-info":[{"award-number":["DK108736"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","award":["2-SRA-2021-1024-S-B"],"award-info":[{"award-number":["2-SRA-2021-1024-S-B"]}],"id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","award":["3-SRA-2021-1033-S-B"],"award-info":[{"award-number":["3-SRA-2021-1033-S-B"]}],"id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.addr.2024.115179","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T08:16:05Z","timestamp":1706429765000},"page":"115179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery"],"prefix":"10.1016","volume":"206","author":[{"given":"T.R.","family":"Lansberry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0573-0646","authenticated-orcid":false,"given":"C.L.","family":"Stabler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2024.115179_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2024.115179_b0010","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.2337\/dc21-0770","article-title":"Adult-onset type 1 diabetes: current understanding and challenges","volume":"44","author":"Leslie","year":"2021","journal-title":"Diabetes Care."},{"key":"10.1016\/j.addr.2024.115179_b0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.mjt.0000178767.67857.63","article-title":"Autoimmune Destruction of pancreatic \u03b2 Cells","volume":"12","author":"Yoon","year":"2005","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.addr.2024.115179_b0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.addr.2024.115179_b0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ddmec.2004.11.015","article-title":"Mechanisms underlying type I diabetes","volume":"1","author":"Bresson","year":"2004","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"10.1016\/j.addr.2024.115179_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419844521","article-title":"Therapies for type 1 diabetes: current scenario and future perspectives","volume":"12","author":"Pathak","year":"2019","journal-title":"Clin. Med. Insights Endocrinol. Diabetes."},{"key":"10.1016\/j.addr.2024.115179_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00343","article-title":"T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front. Endocrinol. (lausanne)"},{"key":"10.1016\/j.addr.2024.115179_b0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev-pathol-042320-094846","article-title":"Engineering \u03b2 Cell replacement therapies for type 1 diabetes: biomaterial advances and considerations for macroscale constructs","volume":"17","author":"Quizon","year":"2021","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.addr.2024.115179_b0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/er.2018-00154","article-title":"Pancreatic islet transplantation in humans: Recent progress and future directions","volume":"40","author":"Rickels","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.addr.2024.115179_b0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ags3.12214","article-title":"Current state and future evolution of pancreatic islet transplantation","volume":"3","author":"Anazawa","year":"2019","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.addr.2024.115179_b0055","series-title":"Bio-Inspired Mater. Biomed","first-page":"327","article-title":"Engineering immune responses to allografts","author":"Frei","year":"2014"},{"key":"10.1016\/j.addr.2024.115179_b0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.addr.2024.115179_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2023.06.038","article-title":"Enhancing longevity of immunoisolated pancreatic islet grafts by modifying both the intracapsular and extracapsular environment","author":"Qin","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115179_b0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/19382014.2018.1428511","article-title":"The journey of islet cell transplantation and future development","volume":"10","author":"Gamble","year":"2018","journal-title":"Islets."},{"key":"10.1016\/j.addr.2024.115179_b0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ajt.16785","article-title":"The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program","volume":"22","author":"Forbes","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00125-022-05804-4","article-title":"Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the collaborative islet transplant registry","volume":"66","author":"Hering","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2024.115179_b0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4093\/dmj.2011.35.3.199","article-title":"Clinical allogeneic and autologous islet cell transplantation: Update","volume":"35","author":"Matsumoto","year":"2011","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.addr.2024.115179_b0090","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","article-title":"Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes","volume":"28","author":"Ramzy","year":"2021","journal-title":"Cell Stem Cell."},{"key":"10.1016\/j.addr.2024.115179_b0095","doi-asserted-by":"crossref","DOI":"10.2337\/db18-138-OR","article-title":"Initial clinical evaluation of VC-01TM Combination Product\u2014A stem cell-derived islet replacement for type 1 diabetes (T1D)","volume":"67","author":"Henry","year":"2018","journal-title":"Diabetes."},{"key":"10.1016\/j.addr.2024.115179_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100466","article-title":"Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device","volume":"2","author":"Shapiro","year":"2021","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.addr.2024.115179_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41574-022-00790-4","article-title":"A spectacular year for islet and stem cell transplantation","volume":"19","author":"Shapiro","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.addr.2024.115179_b0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41587-022-01246-w","article-title":"Diabetes cell therapies take evasive action","volume":"40","author":"Dolgin","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2024.115179_b0115","unstructured":"Vertex Presents Positive VX-880 Results From Ongoing Phase 1\/2 Study in Type 1 Diabetes at the American Diabetes Association 83rd Scientific Sessions | Vertex Pharmaceuticals, Boston, 2023. https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/vertex-presents-positive-vx-880-results-ongoing-phase-12-study."},{"key":"10.1016\/j.addr.2024.115179_b0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.scr.2009.02.002","article-title":"Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies","volume":"2","author":"Hentze","year":"2009","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.addr.2024.115179_b0125","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/stem.471","article-title":"Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection","volume":"28","author":"Gutierrez-Aranda","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2024.115179_b0130","first-page":"5705","article-title":"Teratoma formation in immunocompetent mice after syngeneic and allogeneic implantation of germline capable mouse embryonic stem cells, asian pacific","volume":"14","author":"Aldahmash","year":"2013","journal-title":"J Cancer Prev."},{"key":"10.1016\/j.addr.2024.115179_b0135","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5966\/sctm.2016-0201","article-title":"Preventing pluripotent cell teratoma in regenerative medicine applied to hematology disorders","volume":"6","author":"Bedel","year":"2017","journal-title":"Stem. Cells Transl. Med."},{"key":"10.1016\/j.addr.2024.115179_b0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13402-019-00469-5","article-title":"CD47: role in the immune system and application to cancer therapy","volume":"43","author":"Hayat","year":"2020","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.addr.2024.115179_b0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2024.115179_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.adg5794","article-title":"Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice","volume":"15","author":"Hu","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2024.115179_b0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s40778-022-00221-0","article-title":"Immune editing: overcoming immune barriers in stem cell transplantation","volume":"8","author":"Meissner","year":"2022","journal-title":"Curr. Stem Cell Reports."},{"key":"10.1016\/j.addr.2024.115179_b0165","doi-asserted-by":"crossref","first-page":"a007781","DOI":"10.1101\/cshperspect.a007781","article-title":"Antigen targets of type 1 diabetes autoimmunity","volume":"2","author":"Roep","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.addr.2024.115179_b0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-2007-978750","article-title":"Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice","volume":"31","author":"Kash","year":"1999","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.addr.2024.115179_b0175","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.4049\/jimmunol.178.12.7503","article-title":"The innate immune system in allograft rejection and tolerance","volume":"178","author":"LaRosa","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jhbp.891","article-title":"Clinical islet transplantation: current progress and new frontiers","volume":"28","author":"Marfil-Garza","year":"2021","journal-title":"J. Hepatobiliary. Pancreat. Sci."},{"key":"10.1016\/j.addr.2024.115179_b0185","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2337\/diabetes.54.6.1755","article-title":"Tissue factor produced by the endocrine cells of the islets of langerhans is associated with a negative outcome of clinical islet transplantation","volume":"54","author":"Johansson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2024.115179_b0190","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(02)12020-4","article-title":"Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation","volume":"360","author":"Moberg","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.addr.2024.115179_b0195","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0140-6736(02)12033-2","article-title":"Type I diabetes: a role for tissue factor in pancreatic islet transplantation?","volume":"360","author":"Peppelenbosch","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.addr.2024.115179_b0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.addr.2017.05.012","article-title":"Bio-synthetic materials for immunomodulation of islet transplants","volume":"114","author":"Foster","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115179_b0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/ti.2022.10817","article-title":"Genetic engineering of immune evasive stem cell-derived islets","volume":"35","author":"Sackett","year":"2022","journal-title":"Transpl. Int."},{"key":"10.1016\/j.addr.2024.115179_b0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOT.0b013e32834254cf","article-title":"Natural killer cells in rejection and tolerance of solid organ allografts","volume":"16","author":"Benichou","year":"2011","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.01659","article-title":"Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells","volume":"3","author":"Sojka","year":"2014","journal-title":"Elife."},{"key":"10.1016\/j.addr.2024.115179_b0225","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/cmi.2017.72","article-title":"Liver-resident NK cells and their potential functions","volume":"14","author":"Peng","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.actbio.2021.03.038","article-title":"Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies","volume":"133","author":"Martin","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115179_b0235","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2337\/diabetes.51.1.66","article-title":"\u03b2-Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia","volume":"51","author":"Biarn\u00e9s","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.addr.2024.115179_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.02548","article-title":"T cell allorecognition pathways in solid organ transplantation","volume":"9","author":"Siu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0245","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/TP.0b013e3181891d8b","article-title":"Endothelial cells in allograft rejection","volume":"86","author":"Al-Lamki","year":"2008","journal-title":"Transplantation."},{"key":"10.1016\/j.addr.2024.115179_b0250","doi-asserted-by":"crossref","first-page":"2003708","DOI":"10.1002\/advs.202003708","article-title":"Local immunomodulatory strategies to prevent allo-rejection in transplantation of insulin-producing cells","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115179_b0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-immunol-032414-112014","article-title":"T Cell Fate at the Single-Cell Level","volume":"34","author":"Buchholz","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0260","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.it.2012.01.010","article-title":"Metabolic pathways in T cell fate and function","volume":"33","author":"Gerriets","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41577-020-00426-6","article-title":"How transcription factors drive choice of the T cell fate","volume":"21","author":"Hosokawa","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.actbio.2021.04.023","article-title":"T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response","volume":"133","author":"Adusei","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115179_b0275","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tem.2006.03.006","article-title":"B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes","volume":"17","author":"Silveira","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.addr.2024.115179_b0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actbio.2021.05.039","article-title":"Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes","volume":"133","author":"Samojlik","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115179_b0285","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.1700856","article-title":"Simultaneous recognition of allogeneic MHC and cognate autoantigen by autoreactive T cells in transplant rejection","volume":"200","author":"Burrack","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: Na\u00efve to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.addr.2024.115179_b0295","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrneph.2016.9","article-title":"Memory T cells in organ transplantation: progress and challenges","volume":"12","author":"Espinosa","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.addr.2024.115179_b0300","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion","volume":"5","author":"Pearl","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0305","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.4049\/jimmunol.176.8.4632","article-title":"Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it","volume":"176","author":"Neujahr","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0310","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-7020-6896-6.00018-1","article-title":"Regulatory immune cells","author":"Wing","year":"2019","journal-title":"Clin. Immunol., Elsevier"},{"key":"10.1016\/j.addr.2024.115179_b0315","doi-asserted-by":"crossref","unstructured":"K.K.K. Kond\u011blkov\u00e1, D. Vokurkov\u00e1, J. Krejsek, L. Borsk\u00e1, Z. Fiala, A. Ctirad, C. Andr\u00fds, Regulatory T cells (Treg) and Their Roles in Immune System with Respect to Immunopathological Disorders, Acta Medica (Hradec Kral. Czech Republic). 53 (2010) 73\u201377. 10.14712\/18059694.2016.63.","DOI":"10.14712\/18059694.2016.63"},{"key":"10.1016\/j.addr.2024.115179_b0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrneph.2010.101","article-title":"An update on regulatory T cells in transplant tolerance and rejection","volume":"6","author":"Li","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.addr.2024.115179_b0325","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3227","article-title":"Regulatory immune cells in transplantation","volume":"12","author":"Wood","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0330","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0335","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015487","article-title":"Immunosuppressive drug therapy","volume":"3","author":"Hartono","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.addr.2024.115179_b0340","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CNQ.0000000000000117","article-title":"Immunosuppression in solid-organ transplantation essentials and practical tips","volume":"39","author":"Jasiak","year":"2016","journal-title":"Crit. Care Nurs. q."},{"key":"10.1016\/j.addr.2024.115179_b0345","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2024.115179_b0350","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5500\/wjt.v11.i11.443","article-title":"Current status of glucocorticoid usage in solid organ transplantation","volume":"11","author":"Dashti-Khavidaki","year":"2021","journal-title":"World J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0355","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11892-013-0414-8","article-title":"Biologic agents in islet transplantation","volume":"13","author":"Gala-Lopez","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.addr.2024.115179_b0360","doi-asserted-by":"crossref","DOI":"10.1097\/MOT.0000000000000546","article-title":"Clinical islet transplantation: is the future finally now?","volume":"23","author":"Pepper","year":"2018","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0365","first-page":"1625","article-title":"Immunosuppression in islet transplantation","volume":"118","author":"Van Belle","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2024.115179_b0370","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.4049\/jimmunol.164.11.5761","article-title":"FTY720 immunosuppression impairs effector t cell peripheral homing without affecting induction, expansion, and memory","volume":"164","author":"Pinschewer","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0375","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI200423235","article-title":"Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus","volume":"114","author":"Rother","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2024.115179_b0380","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/ijms23031592","article-title":"Implantable immunosuppressant delivery to prevent rejection in transplantation","volume":"23","author":"Anggelia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2024.115179_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100075","article-title":"Biologics vs. small molecules: drug costs and patient access","volume":"9","author":"Makurvet","year":"2021","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.addr.2024.115179_b0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology."},{"key":"10.1016\/j.addr.2024.115179_b0395","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0400","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-198611020-00002","article-title":"Clinical pharmacokinetics of cyclosporin","volume":"11","author":"Ptachcinski","year":"1986","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2024.115179_b0405","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/phar.2481","article-title":"Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management","volume":"41","author":"Pilch","year":"2021","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.addr.2024.115179_b0410","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003088-200140040-00004","article-title":"Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients","volume":"40","author":"Wallemacq","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2024.115179_b0415","first-page":"563","article-title":"PharmGKB summary, Pharmacogenet","volume":"23","author":"Barbarino","year":"2013","journal-title":"Genomics."},{"key":"10.1016\/j.addr.2024.115179_b0420","doi-asserted-by":"crossref","first-page":"2100965","DOI":"10.1002\/adhm.202100965","article-title":"Advances in encapsulation and delivery strategies for islet transplantation","volume":"10","author":"Wu","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2024.115179_b0425","doi-asserted-by":"crossref","first-page":"e56799","DOI":"10.1371\/journal.pone.0056799","article-title":"Tacrolimus inhibits the revascularization of isolated pancreatic islets","volume":"8","author":"Nishimura","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.addr.2024.115179_b0430","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.clpt.6100317","article-title":"Rapamycin: Something old, something new, sometimes borrowed and now renewed","volume":"82","author":"Hartford","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2024.115179_b0435","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0024-3205(95)02233-3","article-title":"Mechanism of action of the immunosuppressant rapamycin","volume":"58","author":"Dumont","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2024.115179_b0440","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.2147\/OTT.S205160","article-title":"Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A\/VEGFR-2 and VEGF-C\/ VEGFR-3 expression","volume":"12","author":"Wang","year":"2019","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.addr.2024.115179_b0445","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1432-2277.2009.00841.x","article-title":"Rapamycin, but not cyclosporine A, inhibits vascularization and incorporation of implanted surgical meshes","volume":"22","author":"Laschke","year":"2009","journal-title":"Transpl. Int."},{"key":"10.1016\/j.addr.2024.115179_b0450","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/db13-0106","article-title":"Evidence for rapamycin toxicity in pancreatic \u03b2-Cells and a review of the underlying molecular mechanisms","volume":"62","author":"Barlow","year":"2013","journal-title":"Diabetes."},{"key":"10.1016\/j.addr.2024.115179_b0455","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation."},{"key":"10.1016\/j.addr.2024.115179_b0460","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007890-200003150-00028","article-title":"Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation","volume":"69","author":"Johnson","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115179_b0465","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1399-0012.2007.00757.x","article-title":"Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient","volume":"22","author":"Kaplan","year":"2007","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0470","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/0091270005278599","article-title":"Mycophenolate mofetil in islet cell transplant: Variable pharmacokinetics but good correlation between total and unbound concentrations","volume":"45","author":"Jacobson","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2024.115179_b0475","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/FPC.0000000000000010","article-title":"PharmGKB summary: mycophenolic acid pathway","volume":"24","author":"Lamba","year":"2014","journal-title":"Pharmacog. Genomics"},{"key":"10.1016\/j.addr.2024.115179_b0480","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-3083.1991.tb03746.x","article-title":"Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0485","first-page":"207","article-title":"The Role of de novo Purine Synthesis in Lymphocyte Transformation, in","author":"Allison","year":"1977","journal-title":"Purine Pyrimidine Metab."},{"key":"10.1016\/j.addr.2024.115179_b0490","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00007691-199512000-00023","article-title":"Mechanism of Action of Mycophenolate Mofetil","volume":"17","author":"Ransom","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.addr.2024.115179_b0495","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0022-3565(24)35215-2","article-title":"Pharmacodynamics of immunosuppression by mycophenolic acid: Inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics","volume":"291","author":"Gummert","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2024.115179_b0500","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/41.7.1011","article-title":"Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics","volume":"41","author":"Nowak","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.addr.2024.115179_b0505","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2024.115179_b0510","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0190-9622(18)30747-3","article-title":"Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses","volume":"37","author":"Kitchin","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2024.115179_b0515","first-page":"1","article-title":"Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2024.115179_b0520","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.clpt.2003.12.009","article-title":"Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients","volume":"75","author":"Kuypers","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2024.115179_b0525","unstructured":"O. Mohammadi, T.A. Kassim, Azathioprine, in: StatPearls, StatPearls Publishing, Treasure Island, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542190\/."},{"key":"10.1016\/j.addr.2024.115179_b0530","unstructured":"P.J. Morris, Azathioprine, in: LiverTox Clin. Res. Inf. Drug-Induced Liver Inj., National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 2012: pp. 216\u2013220. 10.1016\/B978-1-4557-4096-3.00015-5."},{"key":"10.1016\/j.addr.2024.115179_b0535","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/micr.20360","article-title":"Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice","volume":"27","author":"Liu","year":"2007","journal-title":"Microsurgery"},{"key":"10.1016\/j.addr.2024.115179_b0540","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.transproceed.2011.09.008","article-title":"FTY720-loaded poly(DL-lactide-co-glycolide) electrospun scaffold significantly increases microvessel density over 7 days in streptozotocin-induced diabetic C57b16\/J mice: preliminary results","volume":"43","author":"Bowers","year":"2011","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.addr.2024.115179_b0545","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.addr.2024.115179_b0550","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/CPJ.0b013e31823c51dd","article-title":"Fingolimod","volume":"1","author":"Hyland","year":"2011","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.addr.2024.115179_b0555","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11596550-000000000-00000","article-title":"Clinical pharmacokinetics of fingolimod","volume":"51","author":"David","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2024.115179_b0560","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/NOR.0000000000000595","article-title":"Corticosteroids","volume":"38","author":"Kapugi","year":"2019","journal-title":"Orthop. Nurs."},{"key":"10.1016\/j.addr.2024.115179_b0565","unstructured":"D.B. Johnson, M.J. Lopez, B. Kelley, Dexamethasone, in: StatPearls, Elsevier, 2023: pp. 1\u20136. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482130\/ (accessed February 19, 2022)."},{"key":"10.1016\/j.addr.2024.115179_b0570","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2344\/0003-3006-60.1.25","article-title":"Basic and clinical pharmacology of glucocorticosteroids","volume":"60","author":"Becker","year":"2013","journal-title":"Anesth. Prog."},{"key":"10.1016\/j.addr.2024.115179_b0575","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1089\/ten.tea.2014.0487","article-title":"Controlled release of dexamethasone from organosilicone constructs for local modulation of inflammation in islet transplantation","volume":"21","author":"Weaver","year":"2015","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.addr.2024.115179_b0580","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.freeradbiomed.2009.08.010","article-title":"Protection of insulin-producing cells against toxicity of dexamethasone by catalase overexpression","volume":"47","author":"Roma","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.addr.2024.115179_b0585","doi-asserted-by":"crossref","unstructured":"T.M. Brusko, H.A. Russ, C.L. Stabler, Strategies for durable \u03b2 cell replacement in type 1 diabetes, Science (80-.). 373 (2021) 516\u2013522. 10.1126\/science.abh1657.","DOI":"10.1126\/science.abh1657"},{"key":"10.1016\/j.addr.2024.115179_b0590","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.clinthera.2023.05.003","article-title":"Teplizumab","volume":"45","author":"Beninger","year":"2023","journal-title":"Clin. Ther."},{"key":"10.1016\/j.addr.2024.115179_b0595","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/9781444355628.ch22","article-title":"Transplantation Immunotherapy with Antithymocyte Globulin (ATG), in","author":"Dzuris","year":"2010","journal-title":"Immunother. Transplant., Wiley"},{"key":"10.1016\/j.addr.2024.115179_b0600","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0605","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1517\/13543784.9.9.2147","article-title":"CTLA4-Ig: a novel immunosuppressive agent","volume":"9","author":"Najafian","year":"2000","journal-title":"Expert Opin. Investig. Drugs."},{"key":"10.1016\/j.addr.2024.115179_b0610","first-page":"1","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","author":"Ramos","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2024.115179_b0615","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/2047-1440-2-S1-S5","article-title":"Alemtuzumab induction therapy in solid organ transplantation","volume":"2","author":"Friend","year":"2013","journal-title":"Transplant. Res."},{"key":"10.1016\/j.addr.2024.115179_b0620","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/TP.0b013e31819025e5","article-title":"Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes","volume":"86","author":"Froud","year":"2008","journal-title":"Transplantation."},{"key":"10.1016\/j.addr.2024.115179_b0625","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2024.115179_b0630","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/373444a0","article-title":"Fas(CD95)\/FasL interactions required for programmed cell death after T-cell activation","volume":"373","author":"Ju","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115179_b0635","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"Ogasawara","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115179_b0640","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00063030-200115110-00005","article-title":"Daclizumab","volume":"15","author":"Carswell","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.addr.2024.115179_b0645","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/TP.0b013e31826d4672","article-title":"Costimulation blockade: Current perspectives and implications for therapy","volume":"95","author":"Kinnear","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115179_b0650","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.12330","article-title":"ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates","volume":"13","author":"Watanabe","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0655","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12356","article-title":"Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression","volume":"25","author":"Shin","year":"2018","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.addr.2024.115179_b0660","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/ajt.15591","article-title":"Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study","volume":"20","author":"Harland","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0665","doi-asserted-by":"crossref","unstructured":"J.S.S. Shin, J.S.M.S.J.M. Kim, J.S.M.S.J.M. Kim, B.H.H. Min, Y.H.H. Kim, H.J.J. Kim, J.Y.Y. Jang, I.H.H. Yoon, H.J.J. Kang, J.S.M.S.J.M. Kim, E.S.S. Hwang, D.G.G. Lim, W.W.W. Lee, J. Ha, K.C.C. Jung, S.H.H. Park, S.J.J. Kim, C.G.G. Park, Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets, Am. J. Transplant. 15 (2015) 2837\u20132850. 10.1111\/ajt.13345.","DOI":"10.1111\/ajt.13345"},{"key":"10.1016\/j.addr.2024.115179_b0670","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2024.115179_b0675","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.TP.0000110291.29370.C0","article-title":"Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates","volume":"77","author":"Koyama","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115179_b0680","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MOT.0000000000000656","article-title":"The past, present, and future of costimulation blockade in organ transplantation","volume":"24","author":"Schroder","year":"2019","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0685","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/psp4.12224","article-title":"Pharmacokinetics of Monoclonal Antibodies","volume":"6","author":"Ryman","year":"2017","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.addr.2024.115179_b0690","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-065X.2009.00781.x","article-title":"Costimulatory pathways in transplantation: challenges and new developments","volume":"229","author":"Li","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2024.115179_b0695","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-017-0002-5","article-title":"Targeting IL-2: an unexpected effect in treating immunological diseases","volume":"3","author":"Ye","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.addr.2024.115179_b0700","article-title":"NKTR-358: a novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases","volume":"4","author":"Dixit","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.addr.2024.115179_b0705","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0710","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.1800907","article-title":"IL-2\/CD25: A long-acting fusion protein that promotes immune tolerance by selectively targeting the IL-2 receptor on regulatory T cells","volume":"201","author":"Ward","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0715","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1600-6143.2004.00566.x","article-title":"TGF-\u03b2 induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors","volume":"4","author":"Fu","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0720","first-page":"1484","article-title":"Immunosuppressive PLGA TGF-\u03b21 microparticles induce polyclonal and antigen-specific regulatory T cells for local immunomodulation of allogeneic islet transplants","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0725","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2018.09.008","article-title":"Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells","volume":"339","author":"Kumar","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0730","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-\u03b2 and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0735","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0966-3274(96)80015-3","article-title":"TGF-\u03b21 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells","volume":"4","author":"Bonham","year":"1996","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b0740","first-page":"1","article-title":"Evaluation of biomaterial scaffold delivery of IL-33 as a localized immunomodulatory agent to support cell transplantation in adipose tissue","volume":"1","author":"Liu","year":"2018","journal-title":"J. Immunol. Regen. Med."},{"key":"10.1016\/j.addr.2024.115179_b0745","doi-asserted-by":"crossref","unstructured":"L.-Y.Y. Hung, Y. Tanaka, K. Herbine, C. Pastore, B. Singh, A. Ferguson, N. Vora, B. Douglas, K. Zullo, E.M. Behrens, T. Li Hui Tan, M.A. Kohanski, P. Bryce, C. Lin, T. Kambayashi, D.R. Reed, B.L. Brown, N.A. Cohen, D.R. Herbert, T.L.H. Tan, M.A. Kohanski, P. Bryce, C. Lin, T. Kambayashi, D.R. Reed, B.L. Brown, N.A. Cohen, D.R. Herbert, Cellular context of IL-33 expression dictates impact on anti-helminth immunity, Sci. Immunol. 5 (2020) 498\u2013503. 10.1126\/sciimmunol.abc6259.","DOI":"10.1126\/sciimmunol.abc6259"},{"key":"10.1016\/j.addr.2024.115179_b0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05382.x","article-title":"An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents","volume":"1182","author":"Donnelly","year":"2009","journal-title":"Ann. n. y. Acad. Sci."},{"key":"10.1016\/j.addr.2024.115179_b0755","first-page":"1049","article-title":"Cytokine mediated tissue fibrosis","volume":"2013","author":"Borthwick","year":"1832","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.addr.2024.115179_b0760","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41565-021-01048-2","article-title":"Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability","volume":"17","author":"Burke","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2024.115179_b0765","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.addr.2024.115179_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.101063","article-title":"Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes","volume":"83","author":"Zeynaloo","year":"2022","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.addr.2024.115179_b0775","first-page":"2117","article-title":"Pancreatic islet transplantation","volume":"73","author":"Anazawa","year":"2015","journal-title":"Nihon Rinsho."},{"key":"10.1016\/j.addr.2024.115179_b0780","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130770","article-title":"Tacrolimus- and sirolimus-induced human \u03b2 cell dysfunction is reversible and preventable","volume":"5","author":"Dai","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.addr.2024.115179_b0785","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1007\/s00125-011-2243-0","article-title":"Advancing islet transplantation: From engraftment to the immune response","volume":"54","author":"Gibly","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2024.115179_b0790","doi-asserted-by":"crossref","first-page":"e1705328","DOI":"10.1002\/adma.201705328","article-title":"Advances in biomaterials for drug delivery","volume":"30","author":"Fenton","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115179_b0795","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-6143.2005.00748.x","article-title":"Pharmacokinetic Principles of Immunosuppressive Drugs","volume":"5","author":"Titte","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0800","doi-asserted-by":"crossref","unstructured":"Y. Mei, C. He, C. Gao, P. Zhu, G. Lu, H. Li, 3D-Printed Degradable Anti-Tumor Scaffolds for Controllable Drug Delivery, Int. J. Bioprinting. 7 (2021) 1\u201310. 10.18063\/ijb.v7i4.418.","DOI":"10.18063\/ijb.v7i4.418"},{"key":"10.1016\/j.addr.2024.115179_b0805","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.colsurfb.2016.01.040","article-title":"Effective delivery of immunosuppressive drug molecules by silica coated iron oxide nanoparticles","volume":"142","author":"Hwang","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2024.115179_b0810","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002365","article-title":"Engineering prodrug nanomedicine for cancer immunotherapy","volume":"7","author":"Yang","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115179_b0815","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/pharmaceutics11080413","article-title":"A mixed thermosensitive hydrogel system for sustained delivery of tacrolimus for immunosuppressive therapy","volume":"11","author":"Lin","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115179_b0820","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2007.07.045","article-title":"Preparation of rapamycin-loaded chitosan\/PLA nanoparticles for immunosuppression in corneal transplantation","volume":"349","author":"Yuan","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115179_b0825","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/gels4030061","article-title":"Encapsulation of biological agents in hydrogels for therapeutic applications","volume":"4","author":"P\u00e9rez-Luna","year":"2018","journal-title":"Gels"},{"key":"10.1016\/j.addr.2024.115179_b0830","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1111\/ajt.13878","article-title":"Micro and nano material carriers for immunomodulation","volume":"16","author":"Bracho-Sanchez","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0835","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.3390\/ma14185344","article-title":"Improvement of drug release and compatibility between hydrophilic drugs and hydrophobic nanofibrous composites","volume":"14","author":"Haroosh","year":"2021","journal-title":"Materials (basel)."},{"key":"10.1016\/j.addr.2024.115179_b0840","doi-asserted-by":"crossref","unstructured":"M. Sanopoulou, K.G. Papadokostaki, Controlled drug release systems: Mechanisms and kinetics, in: Biomed. Membr. (Bio)Artificial Organs, 2017: pp. 1\u201333. 10.1142\/9789813223974_0001.","DOI":"10.1142\/9789813223974_0001"},{"key":"10.1016\/j.addr.2024.115179_b0845","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2015.08.049","article-title":"Controlled drug release for tissue engineering","volume":"219","author":"Rambhia","year":"2015","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2024.115179_b0850","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/term.2464","article-title":"Local delivery of fingolimod from three-dimensional scaffolds impacts islet graft efficacy and microenvironment in a murine diabetic model","volume":"12","author":"Frei","year":"2018","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.addr.2024.115179_b0855","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.11.004","article-title":"Local release of dexamethasone from macroporous scaffolds accelerates islet transplant engraftment by promotion of anti-inflammatory M2 macrophages","volume":"114","author":"Jiang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115179_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120232","article-title":"Neovascularized implantable cell homing encapsulation platform with tunable local immunosuppressant delivery for allogeneic cell transplantation","volume":"257","author":"Paez-Mayorga","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115179_b0865","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1038\/s41467-022-35629-z","article-title":"Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats","volume":"13","author":"Paez-Mayorga","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2024.115179_b0870","article-title":"Localization of drug biodistribution in a 3D-bioengineered subcutaneous neovascularized microenvironment","volume":"16","author":"Capuani","year":"2022","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.addr.2024.115179_b0875","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1039\/C9BM01487J","article-title":"Clickable, acid labile immunosuppressive prodrugs for in vivo targeting","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2024.115179_b0880","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/TP.0000000000002283","article-title":"Local injections of tacrolimus-loaded hydrogel reduce systemic immunosuppression-related toxicity in vascularized composite allotransplantation","volume":"102","author":"Dzhonova","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115179_b0885","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.msec.2018.11.051","article-title":"Biodegradable and injectable hydrogels as an immunosuppressive drug delivery system","volume":"98","author":"Kim","year":"2019","journal-title":"Mater. Sci. Eng. c."},{"key":"10.1016\/j.addr.2024.115179_b0890","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.actbio.2019.02.016","article-title":"Advances in immunotherapy delivery from implantable and injectable biomaterials","volume":"88","author":"Leach","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115179_b0895","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41578-019-0106-3","article-title":"Macroscale biomaterials strategies for local immunomodulation","volume":"4","author":"Dellacherie","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2024.115179_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2022.112723","article-title":"Silk sericin\/PLGA electrospun scaffolds with anti-inflammatory drug-eluting properties for periodontal tissue engineering","volume":"133","author":"Chachlioutaki","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.addr.2024.115179_b0905","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.msec.2018.07.056","article-title":"Controlled release of monoclonal antibodies from poly-l-lysine-coated alginate spheres within a scaffolded implant mitigates autoimmune responses to transplanted islets and limits systemic antibody toxicity","volume":"93","author":"Vernon","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2024.115179_b0910","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.1126\/sciadv.abf9221","article-title":"Localized drug delivery graphene bioscaffolds for cotransplantation of islets and mesenchymal stem cells","volume":"7","author":"Razavi","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2024.115179_b0915","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/ten.tea.2020.0287","article-title":"controlled release of anti-inflammatory and proangiogenic factors from macroporous scaffolds","volume":"27","author":"Liang","year":"2021","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.addr.2024.115179_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120452","article-title":"Gelatine-based drug-eluting bandage contact lenses: effect of PEGDA concentration and manufacturing technique","volume":"599","author":"Zidan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115179_b0925","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/jbm.a.37429","article-title":"A hydrogel platform for co-delivery of immunomodulatory proteins for pancreatic islet allografts","volume":"110","author":"Medina","year":"2022","journal-title":"J. Biomed. Mater. Res. Part a."},{"key":"10.1016\/j.addr.2024.115179_b0930","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1021\/acsbiomaterials.7b00218","article-title":"Localized immunomodulatory silk macrocapsules for islet-like spheroid formation and sustained insulin production","volume":"3","author":"Kumar","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.addr.2024.115179_b0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.09.037","article-title":"Immunomodulatory injectable silk hydrogels maintaining functional islets and promoting anti-inflammatory M2 macrophage polarization","volume":"187","author":"Kumar","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115179_b0940","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2015.11.065","article-title":"Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets","volume":"80","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115179_b0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14020359","article-title":"Poly(Lactic Acid)-based microparticles for drug delivery applications: an overview of recent advances","volume":"14","author":"Vlachopoulos","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115179_b0950","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/abdcac","article-title":"Enhancing islet transplantation using a biocompatible collagen-PDMS bioscaffold enriched with dexamethasone-microplates","volume":"13","author":"Primavera","year":"2021","journal-title":"Biofabrication"},{"key":"10.1016\/j.addr.2024.115179_b0955","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/db07-0507","article-title":"A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes","volume":"57","author":"Phillips","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2024.115179_b0960","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bit.21301","article-title":"Microparticles and nanoparticles for drug delivery","volume":"96","author":"Kohane","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2024.115179_b0965","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1080\/10717544.2017.1377317","article-title":"Single synchronous delivery of FK506-loaded polymeric microspheres with pancreatic islets for the successful treatment of streptozocin-induced diabetes in mice","volume":"24","author":"Pathak","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115179_b0970","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1038\/s41598-019-40404-0","article-title":"Local release of rapamycin by microparticles delays islet rejection within the anterior chamber of the eye","volume":"9","author":"Fan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2024.115179_b0975","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1039\/C3TB21460E","article-title":"Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres","volume":"2","author":"Lewis","year":"2014","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.addr.2024.115179_b0980","doi-asserted-by":"crossref","first-page":"25784","DOI":"10.1073\/pnas.1910701116","article-title":"Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation","volume":"116","author":"Fisher","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2024.115179_b0985","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ajt.15662","article-title":"Co-localized immune protection using dexamethasone-eluting micelles in a murine islet allograft model","volume":"20","author":"Kuppan","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b0990","doi-asserted-by":"crossref","unstructured":"V.P. Menon, A.R. Sudheer, Antioxidant and anti-inflammatory properties of curcumin, in: Mol. Targets Ther. Uses Curcumin Heal. Dis., Springer US, Boston, MA, MA, 2007: pp. 105\u2013125. 10.1007\/978-0-387-46401-5_3.","DOI":"10.1007\/978-0-387-46401-5_3"},{"key":"10.1016\/j.addr.2024.115179_b0995","doi-asserted-by":"crossref","first-page":"25702","DOI":"10.1021\/acsami.6b07897","article-title":"Hybrid congregation of islet single cells and curcumin-loaded polymeric microspheres as an interventional strategy to overcome apoptosis associated with pancreatic islets transplantation","volume":"8","author":"Pathak","year":"2016","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"10.1016\/j.addr.2024.115179_b1000","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00007691-200002000-00006","article-title":"Pharmacokinetics and metabolism of sirolimus","volume":"22","author":"Gallant-Haidner","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.addr.2024.115179_b1005","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1177\/1535370216650053","article-title":"Nanoparticles and direct immunosuppression","volume":"241","author":"Ngobili","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.addr.2024.115179_b1010","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b1015","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1600-6143.2011.03725.x","article-title":"Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival","volume":"11","author":"Shirali","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115179_b1020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/nl203334c","article-title":"Polymeric nanomaterials for islet targeting and immunotherapeutic delivery","volume":"12","author":"Ghosh","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2024.115179_b1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.820969","article-title":"Genistein: a review on its anti-inflammatory properties","volume":"13","author":"Goh","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2024.115179_b1030","doi-asserted-by":"crossref","first-page":"48259","DOI":"10.1021\/acsami.0c10885","article-title":"An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance","volume":"12","author":"Luo","year":"2020","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"10.1016\/j.addr.2024.115179_b1035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijpharm.2011.01.018","article-title":"Preparation of Tacrolimus loaded micelles based on poly(\u03b5- caprolactone)-poly(ethylene glycol)-poly(\u03b5-caprolactone)","volume":"407","author":"Wang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115179_b1040","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K","article-title":"Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis","volume":"43","author":"Barrera","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2024.115179_b1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.887402","article-title":"Targeting lymphatics for nanoparticle drug delivery","volume":"13","author":"McCright","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2024.115179_b1050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0005-2736(89)90078-3","article-title":"Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues","volume":"981","author":"Allen","year":"1989","journal-title":"BBA - Biomembr."},{"key":"10.1016\/j.addr.2024.115179_b1055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejps.2018.11.019","article-title":"Nanomedicines: the magic bullets reaching their target?","volume":"128","author":"Fl\u00fchmann","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2024.115179_b1060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/03639045.2020.1721524","article-title":"Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate","volume":"46","author":"Rezaie Shirmard","year":"2020","journal-title":"Drug Dev Ind. Pharm."},{"key":"10.1016\/j.addr.2024.115179_b1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120182","article-title":"In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition","volume":"256","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115179_b1070","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/term.2029","article-title":"Antifibrotic effect of rapamycin containing polyethylene glycol-coated alginate microcapsule in islet xenotransplantation","volume":"11","author":"Park","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.addr.2024.115179_b1075","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1016\/j.biomaterials.2013.04.016","article-title":"Enhanced function of immuno-isolated islets in diabetes therapy byco-encapsulation with an anti-inflammatory drug","volume":"34","author":"Dang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115179_b1080","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/er.2010-0026","article-title":"Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain","volume":"32","author":"O\u2019Sullivan","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.addr.2024.115179_b1085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41578-019-0112-5","article-title":"Engineering immunomodulatory biomaterials for type 1 diabetes","volume":"4","author":"Stabler","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2024.115179_b1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2022.890410","article-title":"Challenges and opportunities for immunoprofiling using a spatial high-plex technology: the nanostring GeoMx\u00ae digital spatial profiler","volume":"12","author":"Hernandez","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.addr.2024.115179_b1095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.actbio.2021.10.018","article-title":"High-plex expression profiling reveals that implants drive spatiotemporal protein production and innate immune activation for tissue repair","volume":"138","author":"Divakar","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115179_b1100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex digital spatial profiling of proteins and RNA in fixed tissue","volume":"38","author":"Merritt","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2024.115179_b1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.618202","article-title":"The immunobiogram, a novel in vitro assay to evaluate treatment resistance in patients receiving immunosuppressive therapy","volume":"11","author":"Portoles","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2024.115179_b1110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biomaterials.2018.11.015","article-title":"Localized immune tolerance from FasL-functionalized PLG scaffolds","volume":"192","author":"Skoumal","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115179_b1115","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720913876","article-title":"Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment","volume":"29","author":"Lee","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2024.115179_b1120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115179_b1125","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1021\/acsbiomaterials.0c01228","article-title":"Phenomenology of the initial burst release of drugs from PLGA microparticles","volume":"6","author":"Yoo","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.addr.2024.115179_b1130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.actbio.2021.05.028","article-title":"Engineering a macroporous oxygen-generating scaffold for enhancing islet cell transplantation within an extrahepatic site","volume":"130","author":"Liang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115179_b1135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1432-2277.2008.00743.x","article-title":"Rapamycin in islet transplantation: friend or foe?","volume":"22","author":"Berney","year":"2009","journal-title":"Transpl. Int."},{"key":"10.1016\/j.addr.2024.115179_b1140","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/en.2003-1152","article-title":"Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling","volume":"145","author":"Uchizono","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.addr.2024.115179_b1145","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41563-019-0377-5","article-title":"Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations","volume":"18","author":"Farah","year":"2019","journal-title":"Nat. Mater."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:41:22Z","timestamp":1759210882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X24000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":229,"alternative-id":["S0169409X24000012"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2024.115179","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2024.115179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115179"}}